Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
453.77
+7.33 (1.64%)
At close: Feb 20, 2026, 4:00 PM EST
445.01
-8.76 (-1.93%)
After-hours: Feb 20, 2026, 7:38 PM EST
Medpace Holdings Revenue
In the year 2025, Medpace Holdings had annual revenue of $2.53B with 19.97% growth. Medpace Holdings had revenue of $708.45M in the quarter ending December 31, 2025, with 32.03% growth.
Revenue (ttm)
$2.53B
Revenue Growth
+19.97%
P/S Ratio
5.09
Revenue / Employee
$408,102
Employees
6,200
Market Cap
12.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | 421.18M | 19.97% |
| Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
| Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
| Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
| Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
| Dec 31, 2020 | 925.93M | 64.96M | 7.54% |
| Dec 31, 2019 | 860.97M | 156.38M | 22.19% |
| Dec 31, 2018 | 704.59M | 268.44M | 61.55% |
| Dec 31, 2017 | 436.15M | 14.57M | 3.46% |
| Dec 31, 2016 | 421.58M | 62.52M | 17.41% |
| Dec 31, 2015 | 359.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Mettler-Toledo International | 4.03B |
| Charles River Laboratories International | 4.02B |
| Exact Sciences | 3.25B |
MEDP News
- 3 days ago - Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility - PRNewsWire
- 10 days ago - Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial - GlobeNewsWire
- 11 days ago - Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation - Seeking Alpha
- 12 days ago - Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results - Business Wire
- 6 weeks ago - Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026 - Business Wire
- 3 months ago - Wasatch Global Opportunities Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 3 months ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga